70 related articles for article (PubMed ID: 12947345)
1. Amelioration of cyclosporin A effect on microvasculature by endothelin inhibitor.
Wilasrusmee C; Ondocin P; Bruch D; Shah G; Kittur S; Wilasrusmee S; Kittur DS
Surgery; 2003 Aug; 134(2):384-9. PubMed ID: 12947345
[TBL] [Abstract][Full Text] [Related]
2. Angiocidal effect of Cyclosporin A: a new therapeutic approach for pathogenic angiogenesis.
Wilasrusmee C; Yusupov I; Ondocin P; Bruch D; Kittur S; Wilasrusmee S; Kittur DS
Int Angiol; 2005 Dec; 24(4):372-9. PubMed ID: 16355096
[TBL] [Abstract][Full Text] [Related]
3. Role of endothelin-1 in microvascular dysfunction caused by cyclosporin A.
Wilasrusmee C; Da Silva M; Siddiqui J; Bruch D; Kittur S; Wilasrusmee S; Kittur DS
J Am Coll Surg; 2003 Apr; 196(4):584-91. PubMed ID: 12691936
[TBL] [Abstract][Full Text] [Related]
4. Role of endothelin-1 and nitric oxide bioavailability in transplant-related vascular injury: comparative effects of rapamycin and cyclosporine.
Ramzy D; Rao V; Tumiati LC; Xu N; Miriuka S; Delgado D; Ross HJ
Circulation; 2006 Jul; 114(1 Suppl):I214-9. PubMed ID: 16820575
[TBL] [Abstract][Full Text] [Related]
5. [Effect of cyclosporin A dosage on the vascular tone of the thoracic aorta of rats].
Cartier R; Mathieu P; Bouchard D; Buluran J
Ann Chir; 1996; 50(8):667-72. PubMed ID: 9035441
[TBL] [Abstract][Full Text] [Related]
6. A new in vitro model to study endothelial injury.
Wilasrusmee C; Da Silva M; Singh B; Kittur S; Siddiqui J; Bruch D; Wilasrusmee S; Kittur DS
J Surg Res; 2002 May; 104(2):131-6. PubMed ID: 12020132
[TBL] [Abstract][Full Text] [Related]
7. Novel function of ascorbic acid as an angiostatic factor.
Ashino H; Shimamura M; Nakajima H; Dombou M; Kawanaka S; Oikawa T; Iwaguchi T; Kawashima S
Angiogenesis; 2003; 6(4):259-69. PubMed ID: 15166494
[TBL] [Abstract][Full Text] [Related]
8. Angiogenic sprouting from the aortic vascular wall is impaired in the BB rat model of autoimmune diabetes.
Onuta G; Westerweel PE; Zandvoort A; van Riezen M; Rozing J; Hillebrands JL; Verhaar MC
Microvasc Res; 2008 Apr; 75(3):420-5. PubMed ID: 18241893
[TBL] [Abstract][Full Text] [Related]
9. The vascular targeting property of paclitaxel is enhanced by SU6668, a receptor tyrosine kinase inhibitor, causing apoptosis of endothelial cells and inhibition of angiogenesis.
Naumova E; Ubezio P; Garofalo A; Borsotti P; Cassis L; Riccardi E; Scanziani E; Eccles SA; Bani MR; Giavazzi R
Clin Cancer Res; 2006 Mar; 12(6):1839-49. PubMed ID: 16551869
[TBL] [Abstract][Full Text] [Related]
10. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells.
Ma X; Ottino P; Bazan HE; Bazan NG
Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2915-21. PubMed ID: 15326102
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the cardiac angiogenic response to surgical FGF-2 therapy in a Swine endothelial dysfunction model.
Ruel M; Wu GF; Khan TA; Voisine P; Bianchi C; Li J; Li J; Laham RJ; Sellke FW
Circulation; 2003 Sep; 108 Suppl 1():II335-40. PubMed ID: 12970256
[TBL] [Abstract][Full Text] [Related]
12. Fractalkine, a CX3C chemokine, as a mediator of ocular angiogenesis.
You JJ; Yang CH; Huang JS; Chen MS; Yang CM
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5290-8. PubMed ID: 17962485
[TBL] [Abstract][Full Text] [Related]
13. Endothelium-restricted overexpression of human endothelin-1 causes vascular remodeling and endothelial dysfunction.
Amiri F; Virdis A; Neves MF; Iglarz M; Seidah NG; Touyz RM; Reudelhuber TL; Schiffrin EL
Circulation; 2004 Oct; 110(15):2233-40. PubMed ID: 15466627
[TBL] [Abstract][Full Text] [Related]
14. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
[TBL] [Abstract][Full Text] [Related]
15. The effect of flutamide on systemic and renal hemodynamics in Zucker diabetic rats: paradoxic renal vasodilator response to endothelin-1 and TXA2 receptor activation in female sex.
Ajayi AA; Fidelis P
J Cardiovasc Pharmacol; 2006 Nov; 48(5):191-8. PubMed ID: 17110800
[TBL] [Abstract][Full Text] [Related]
16. Intramyocardial injection of low-dose basic fibroblast growth factor or vascular endothelial growth factor induces angiogenesis in the infarcted rabbit myocardium.
Bougioukas I; Didilis V; Ypsilantis P; Giatromanolaki A; Sivridis E; Lialiaris T; Mikroulis D; Simopoulos C; Bougioukas G
Cardiovasc Pathol; 2007; 16(2):63-8. PubMed ID: 17317537
[TBL] [Abstract][Full Text] [Related]
17. Endothelin receptor-mediated vasodilatation: effects of organ culture.
Nilsson D; Wackenfors A; Gustafsson L; Ugander M; Paulsson P; Ingemansson R; Edvinsson L; Malmsjö M
Eur J Pharmacol; 2008 Jan; 579(1-3):233-40. PubMed ID: 17964568
[TBL] [Abstract][Full Text] [Related]
18. Matrigel cytometry: a novel method for quantifying angiogenesis in vivo.
Adini A; Fainaru O; Udagawa T; Connor KM; Folkman J; D'Amato RJ
J Immunol Methods; 2009 Mar; 342(1-2):78-81. PubMed ID: 19109967
[TBL] [Abstract][Full Text] [Related]
19. Recombinant leptin administration improves early angiogenesis in full-thickness skin flaps: an experimental study.
Liapakis IE; Anagnostoulis S; Karayiannakis AJ; Korkolis DP; Lambropoulou M; Arnaud E; Simopoulos CE
In Vivo; 2008; 22(2):247-52. PubMed ID: 18468410
[TBL] [Abstract][Full Text] [Related]
20. Differential role of platelet granular mediators in angiogenesis.
Brill A; Elinav H; Varon D
Cardiovasc Res; 2004 Aug; 63(2):226-35. PubMed ID: 15249180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
